Washington, Mar 3 (ANI): University of Michigan researchers have identified a gene called ATDC that is overexpressed in 90 percent of pancreatic cancers.
The expression of the gene called, Ataxia Telangiectasia Group D Complementing gene (ATDC), is 20 times higher in pancreatic cancer cells than in cells from a normal pancreas.
This gene also makes cancer resistant to chemotherapy. It is most highly expressed at the point ...
Full story